Oculogica

Oculogica, Inc. is a medical device company focused on neuro-diagnostics, specifically in the detection of concussion and traumatic brain injury (TBI). Established in 2013 and headquartered in New York, it has developed the EyeBOX, an innovative eye-tracking device that identifies abnormal eye movement patterns. This technology is significant as it allows for the localization and assessment of brain injuries without the need for baseline data or individual calibration, thereby providing an objective evaluation of concussion. The EyeBOX is the only FDA-authorized baseline-free test to aid in diagnosing mild traumatic brain injury, ensuring that results are not influenced by patient subjectivity. Oculogica aims to meet the needs of both patients and healthcare professionals by delivering important insights into brain health through its advanced diagnostic solutions.